| Literature DB >> 35814719 |
Isabelle Romieu1,2, Neha Khandpur3,4, Aikaterini Katsikari5, Carine Biessy5, Gabriela Torres-Mejía1, Angélica Ángeles-Llerenas1, Isabel Alvarado-Cabrero6, Gloria Inés Sánchez7, Maria Elena Maldonado8, Carolina Porras9, Ana Cecilia Rodriguez9, Maria Luisa Garmendia10, Vèronique Chajés5, Elom K Aglago5, Peggy L Porter11, MingGang Lin11, Mathilde His5, Marc J Gunter5, Inge Huybrechts5, Sabina Rinaldi5.
Abstract
Ultra-processed food intake has been linked to an increased risk of breast cancer in Western populations. No data are available in the Latin American population although the consumption of ultra-processed foods is increasing rapidly in this region. We evaluated the association of ultra-processed food intake to breast cancer risk in a case-control study including 525 cases (women aged 20-45 years) and 525 matched population-based controls from Chile, Colombia, Costa Rica and Mexico. The degree of processing of foods was classified according to the NOVA classification. Overall, the major contributors to ultra-processed food intake were ready-to-eat/heat foods (18.2%), cakes and desserts (16.7%), carbonated and industrial fruit juice beverages (16.7%), breakfast cereals (12.9%), sausages and reconstituted meat products (12.1%), industrial bread (6.1%), dairy products and derivatives (7.6%) and package savoury snacks (6.1%). Ultra-processed food intake was positively associated with the risk of breast cancer in adjusted models (OR T3-T1=1.93; 95% CI=1.11 to 3.35). Specifically, a higher risk was observed with oestrogen receptor positive breast cancer (ORT3-T1=2.44, (95% CI=1.01 to 5.90, P-trend=0.049), while no significant association was observed with oestrogen receptor negative breast cancer (ORT3-T1=1.87, 95% CI=0.43 to 8.13, P-trend=0.36). Our findings suggest that the consumption of ultra-processed foods might increase the risk of breast cancer in young women in Latin America. Further studies should confirm these findings and disentangle specific mechanisms relating ultra-processed food intake and carcinogenic processes in the breast. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: nutrition assessment
Year: 2022 PMID: 35814719 PMCID: PMC9237890 DOI: 10.1136/bmjnph-2021-000335
Source DB: PubMed Journal: BMJ Nutr Prev Health ISSN: 2516-5542
Main characteristics of the population
| Variable | N | Controls | Cases | P value* |
| N=525 | N=525 | |||
| Median (p10–p90) or N (%) | Median (p10–p90) or N (%) | |||
| Age (years) | 1050 | 40 (31–45) | 40 (31–45) | 0.06 |
| Age at menarche (years) | 1050 | 12 (10–15) | 12 (11–15) | 0.93 |
| Pregnancy ever | 911 | 478 (91) | 433 (84) | <0.0001 |
| Age at first full-term pregnancy† | 908 | <0.0001 | ||
| <20 | 180 (37.7) | 123 (28.5) | ||
| 20–25 | 174 (36.5) | 128 (29.7) | ||
| ≥25 | 123 (25.8) | 180 (41.8) | ||
| Age at first full-term pregnancy†(years) | 908 | 21 (16–29) | 23 (17–33) | <0.0001 |
| Age at last full-term pregnancy† (years) | 908 | 28 (22–36) | 30 (22–36) | 0.05 |
| Number of children | 1036 | <0.0001 | ||
| 0 | 47 (9.1) | 92 (17.8) | ||
| 1 | 112 (21.6) | 157 (30.4) | ||
| ≥2 | 360 (69.3) | 268 (51.8) | ||
| Ever breast feed, for parous women | 911 | 443 (92.7) | 383 (88.5) | <0.0001 |
| Cumulated duration of breast feeding† ≥12 months, | 911 | 313 (65.5) | 200 (46.1) | <0.0001 |
| History of benign breast disease | 1050 | 66 (12.6) | 191 (36.4) | <0.0001 |
| Family history of breast cancer | 1050 | 23 (4.4) | 33 (6.3) | 0.18 |
| Daily alcohol intake‡ (g/day) | 898 | 0.92 (0.05–4.95) | 0.83 (0.04–5.53) | 0.15 |
| Daily physical activity§ (hours/day) | 1050 | 3.6 (0.93–8.9) | 2.0 (0.36–8.4) | <0.0001 |
| Education level | 1050 | <0.0001 | ||
| ≤primary school (low) | 103 (19.6) | 65 (12.4) | ||
| secondary school (medium) | 286 (54.5) | 253 (48.2) | ||
| >secondary school (high) | 136 (25.9) | 207 (39.4) | ||
| Ever smoker (yes) | 530 | 285 (54.3) | 245 (46.7) | 0.009 |
|
| ||||
| Height (m) | 1047 | 1.56 (1.50–1.65) | 1.57 (1.49–1.66) | 0.003 |
| Weight (kg) | 1049 | 68 (55–89) | 64 (52–80) | <0.0001 |
| BMI (kg/m²) | 1047 | 28.1 (22.3–36.2) | 26.1 (20.9–32.6) | <0.0001 |
|
| ||||
| Energy (kcal) | 1050 | 2694 (1642–4732) | 2853 (1790–4672) | 0.09 |
| Energy (kcal) for NOVA 1 | 1050 | 1314 (736–2427) | 1372 (801–2472) | 0.25 |
| Energy (kcal) for NOVA 2 | 1050 | 102 (35–289) | 102 (27–247) | 0.16 |
| Energy (kcal) for NOVA 3 | 1050 | 463 (208-893) | 544 (236–997) | 0.09 |
| Energy (kcal) for NOVA 4 | 1050 | 641 (273–1599) | 729 (322–1449) | 0.23 |
|
| ||||
| Plasma industrial trans-fatty acids (%) | 284 | 0.27 (0.16–0.49) | 0.29 (0.16–0.57) | 0.05 |
|
| ||||
| Hormone receptor status** | 332‡‡ | |||
| Oestrogen receptor positive | – | 240 (72) | ||
| Progesterone receptor positive | – | 230 (69) | ||
| HER2 positive | – | 56 (15) | ||
| Triple negative: ER−/PR−/HER2− | – | 70 (21) | ||
| | – |
|
*P value Wilcoxon test from logistic regression conditional on matching factors.
†Among parous women only.
‡Among consumers.
§Daily moderate intensity physical activity.
¶NOVA group 1: Unprocessed or minimally processed foods; NOVA group 2: Processed culinary ingredients, NOVA group 3: Processed foods; NOVA group 4: Ultra-processed food and drink products.
**Immunohistochemistry is so far available for 332 cases. Percentages given for tumour characteristics are based on these 332 cases. Receptors status presented irrespective of other receptors.
††Basal-like: (TN and EGFR +and/or CK5/6+).
BMI, body mass index; CK5/6, cytokeratin 5/6; EGFR, epidermal growth factor receptor; ER, oestrogen receptor; HER2, human epidermal growth factor receptor 2; PR, progesterone receptor; TN, triple negative; UPF, ultra-processed foods.
Figure 2Food groups contributing to ultra-processed foods in our population by countries (Chile, Colombia, Costa Rica and Mexico).
ORs and 95% CI for associations between ultra-processed food intake and risk of breast cancer, overall and by receptor status
| Cases/controls | Model 1* | Model 2† | |
| OR (95% CI) | OR (95% CI) | ||
| All breast cancer‡ | |||
| Tertile 1 | 142/175 | 1.00 (ref.) | 1.00 (ref.) |
| Tertile 2 | 184/175 | 1.27 (0.88 to 1.83) | 1.38 (0.95 to 2.03) |
| Tertile 3 | 199/175 | 1.49 (0.96 to 2.33) | 1.93 (1.11 to 3.35) |
| P-trend | 0.07 | 0.02 | |
| By receptors status | |||
| ER positive | |||
| Tertile 1 | 58/80 | 1.00 (ref.) | 1.00 (ref.) |
| Tertil 2 | 92/80 | 1.37 (0.79 to 2.36) | 1.45 (0.81 to 2.58) |
| Tertile 3 | 90/80 | 1.70 (0.82 to 3.52) | 2.44 (1.01 to 5.90) |
| P-trend | 0.15 | 0.05 | |
| ER negative | |||
| Tertile 1 | 24/31 | 1.00 (ref.) | 1.00 (ref.) |
| Tertile 2 | 32/31 | 1.17 (0.44 to 3.10) | 1.55 (0.55 to 4.37) |
| Tertile 3 | 36/30 | 1.28 (0.44 to 3.72) | 1.87 (0.43 to 8.13) |
| P-trend | 0.64 | 0.36 |
*Model 1: ORs were estimated by logistic regression conditioned on age (±3 years), city district of residence and health insurance institution and adjusted for education, (≤primary/secondary/>secondary), moderate intensity physical activity (continuous), number of full-term pregnancies (continuous), age at first full-term pregnancy (nulliparous/<20; 20–25; ≥25), breast feeding ever (yes/no), BMI (continuous) and total energy intake (continuous).
†Model 2: Additionally adjusted for energy intake from the other NOVA groups (NOVA 1, NOVA 2, NOVA 3 added simultaneously in the model).
‡Cut-off points for tertiles are respectively: Tertile 1=≤495.5; tertile 2=495.5–896.6; tertile 3=>896.6 kcal/day.
BMI, body mass index; ER, oestrogen receptor.